Skip to main content
Erschienen in: Supportive Care in Cancer 9/2012

01.09.2012 | Short Communication

Bone marrow necrosis in a girl with Hodgkin’s disease

verfasst von: Herwig Lackner, Volker Strenger, Petra Sovinz, Christine Beham-Schmid, Alexander Pilhatsch, Martin Benesch, Wolfgang Schwinger, Raphael Ulreich, Sandrin Schmidt, Christian Urban

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Bone marrow necrosis (BMN) is a rare finding in children with malignancy occurring most commonly in children with acute lymphoblastic leukemia. This article describes the first case of a girl who developed BMN during treatment for Hodgkin’s disease. During the second cycle of chemotherapy, she experienced sudden profound bone pain in the lumbosacral region associated with elevated levels of lactate dehydrogenase (LDH), fibrin degradation products (D-Dimer), and alkaline phosphatase as well as pancytopenia and leukoerythroblastosis. MRI studies showed multiple confluent areas with low signal intensity and rim contrast enhancement in all vertebral bodies. Bone marrow biopsy revealed focal necrosis within hypocellular bone marrow. The patient responded quickly to symptomatic treatment with analgetics and heparin; however, elevations of LDH and D-Dimer persisted for 1.5 and 8 months, respectively. Clinicians should be aware of this rare condition to establish the diagnosis and to continue oncologic treatment as early as possible.
Literatur
1.
2.
Zurück zum Zitat Paydas S, Ergin M, Baslamisli F, Yavuz S, Zorludemir S, Sahin B, Bolat FA (2002) Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am F Hematol 70:300–305CrossRef Paydas S, Ergin M, Baslamisli F, Yavuz S, Zorludemir S, Sahin B, Bolat FA (2002) Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am F Hematol 70:300–305CrossRef
3.
Zurück zum Zitat Wade L, Stevenson L (1941) Necrosis of bone marrow with fat embolism in sickle cell anemia. Am J Path 17:47–54PubMed Wade L, Stevenson L (1941) Necrosis of bone marrow with fat embolism in sickle cell anemia. Am J Path 17:47–54PubMed
4.
Zurück zum Zitat Ranaghan L, Morris TC, Desai ZR, Markey GM (1994) Bone marrow necrosis. Am J Hematol 47:225–228PubMedCrossRef Ranaghan L, Morris TC, Desai ZR, Markey GM (1994) Bone marrow necrosis. Am J Hematol 47:225–228PubMedCrossRef
5.
Zurück zum Zitat Resende LSR, Mendes RP, Bacchi MM, Marques SA, Barraviera B, Souza LR, Meira DA, Niéro-Melo L (2009) Bone marrow necrosis related to paracoccidioidomycosis: the first eight cases identified at autopsy. Histopathology 54:486–489 Resende LSR, Mendes RP, Bacchi MM, Marques SA, Barraviera B, Souza LR, Meira DA, Niéro-Melo L (2009) Bone marrow necrosis related to paracoccidioidomycosis: the first eight cases identified at autopsy. Histopathology 54:486–489
6.
Zurück zum Zitat Vora A (2011) Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia. Br J Haematol 155:549–560PubMedCrossRef Vora A (2011) Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia. Br J Haematol 155:549–560PubMedCrossRef
7.
Zurück zum Zitat Lackner H, Benesch M, Moser A, Smolle-Jüttner F, Linhart W, Raith J, Urban C (2005) Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases. J Pediatr Hematol Oncol 27:259–263PubMedCrossRef Lackner H, Benesch M, Moser A, Smolle-Jüttner F, Linhart W, Raith J, Urban C (2005) Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases. J Pediatr Hematol Oncol 27:259–263PubMedCrossRef
8.
Zurück zum Zitat Boavida P, Steward M, Cooney J, Punwani S, Shankar A, Humphries P, Daw S (2011) Avascular necrosis of bone in adolescents with classical Hodgkin lymphoma—a single centre experience. Pediatr Blood Cancer 56(5):892 Boavida P, Steward M, Cooney J, Punwani S, Shankar A, Humphries P, Daw S (2011) Avascular necrosis of bone in adolescents with classical Hodgkin lymphoma—a single centre experience. Pediatr Blood Cancer 56(5):892
9.
Zurück zum Zitat Bermejo A, Gonzales FA, Villegas A, Alarcon C (1995) Bone marrow necrosis. Am J Hematol 50(1):65–66PubMedCrossRef Bermejo A, Gonzales FA, Villegas A, Alarcon C (1995) Bone marrow necrosis. Am J Hematol 50(1):65–66PubMedCrossRef
10.
Zurück zum Zitat Hansen PV, Andersen J, Mygind H (1983) Bone marrow necrosis. Report of a case and a brief review of the literature. Acta Med Scand 214(4):331–336PubMedCrossRef Hansen PV, Andersen J, Mygind H (1983) Bone marrow necrosis. Report of a case and a brief review of the literature. Acta Med Scand 214(4):331–336PubMedCrossRef
11.
Zurück zum Zitat Pui CH, Stass S, Green A (1985) Bone marrow necrosis in children with malignant diseases. Cancer 56:1522–1525PubMedCrossRef Pui CH, Stass S, Green A (1985) Bone marrow necrosis in children with malignant diseases. Cancer 56:1522–1525PubMedCrossRef
12.
Zurück zum Zitat Macfarlane SD, Tauro GP (1986) Acute lymphocytic leukemia in children presenting with bone marrow necrosis. Am J Hematol 22:341–346PubMedCrossRef Macfarlane SD, Tauro GP (1986) Acute lymphocytic leukemia in children presenting with bone marrow necrosis. Am J Hematol 22:341–346PubMedCrossRef
13.
Zurück zum Zitat Devi K, Chakravorty S, Mishra K, Mohanty GN (2000) Bone marrow necrosis in paediatric patients. Indian J Pathol Microbiol 43:47–50PubMed Devi K, Chakravorty S, Mishra K, Mohanty GN (2000) Bone marrow necrosis in paediatric patients. Indian J Pathol Microbiol 43:47–50PubMed
14.
Zurück zum Zitat Abbas AAH, Husain AH, Abdelaal MA, Albaz NM, Yousef AA, Fryer CJH (2001) Acute lymphoblastic leukemia presenting with extensive skeletal lesions and bone marrow necrosis. Med Ped Oncol 37:64–66CrossRef Abbas AAH, Husain AH, Abdelaal MA, Albaz NM, Yousef AA, Fryer CJH (2001) Acute lymphoblastic leukemia presenting with extensive skeletal lesions and bone marrow necrosis. Med Ped Oncol 37:64–66CrossRef
15.
Zurück zum Zitat Inoue S, Monga R, Onwuzurike N (2007) Bone marrow necrosis as a presenting feature of childhood lymphoblastic leukemia. Pediatr Blood Cancer 49:367–368PubMedCrossRef Inoue S, Monga R, Onwuzurike N (2007) Bone marrow necrosis as a presenting feature of childhood lymphoblastic leukemia. Pediatr Blood Cancer 49:367–368PubMedCrossRef
16.
Zurück zum Zitat Shah NR, Landi DB, Kreissman SG, Kulbachi E, Moran C (2011) Presentation and outcome for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review. J Pediatr Hematol Oncol 33:e316–e319PubMedCrossRef Shah NR, Landi DB, Kreissman SG, Kulbachi E, Moran C (2011) Presentation and outcome for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review. J Pediatr Hematol Oncol 33:e316–e319PubMedCrossRef
17.
Zurück zum Zitat Kluge R, Körholz D (2011) Role of FDG-PET in staging and therapy of children with Hodgkin lymphoma. Klin Padiatr 223:315–319PubMedCrossRef Kluge R, Körholz D (2011) Role of FDG-PET in staging and therapy of children with Hodgkin lymphoma. Klin Padiatr 223:315–319PubMedCrossRef
18.
Zurück zum Zitat Lackner H, Sovinz P, Benesch M, Smolle-Jüttner F, Mokry M, Schwinger W, Moser A, Urban C (2009) Management of brain abscesses in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer 52:408–411PubMedCrossRef Lackner H, Sovinz P, Benesch M, Smolle-Jüttner F, Mokry M, Schwinger W, Moser A, Urban C (2009) Management of brain abscesses in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer 52:408–411PubMedCrossRef
19.
Zurück zum Zitat Wendelin G, Lackner H, Schwinger W, Sovinz P, Urban C (2005) Once-per-cycle pegfilgastrim versus daily filgastrim in pediatric patients with Ewing sarcoma. Pediatr Hematol Oncol 27:449–451CrossRef Wendelin G, Lackner H, Schwinger W, Sovinz P, Urban C (2005) Once-per-cycle pegfilgastrim versus daily filgastrim in pediatric patients with Ewing sarcoma. Pediatr Hematol Oncol 27:449–451CrossRef
20.
Zurück zum Zitat te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink (2008) Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica 93(10):1570–1574CrossRef te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink (2008) Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica 93(10):1570–1574CrossRef
21.
Zurück zum Zitat Seki Y, Koike T, Yano M, Aoki S, Hiratsuka M, Fuse I, Aizawa Y (2002) Bone marrow necrosis with dyspnea in a patient with malignant lymphoma and plasma levels of thrombomodulin, tumor necrosis factor-α, and D-Dimer. Am J Hematol 70:250–253PubMedCrossRef Seki Y, Koike T, Yano M, Aoki S, Hiratsuka M, Fuse I, Aizawa Y (2002) Bone marrow necrosis with dyspnea in a patient with malignant lymphoma and plasma levels of thrombomodulin, tumor necrosis factor-α, and D-Dimer. Am J Hematol 70:250–253PubMedCrossRef
Metadaten
Titel
Bone marrow necrosis in a girl with Hodgkin’s disease
verfasst von
Herwig Lackner
Volker Strenger
Petra Sovinz
Christine Beham-Schmid
Alexander Pilhatsch
Martin Benesch
Wolfgang Schwinger
Raphael Ulreich
Sandrin Schmidt
Christian Urban
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1502-z

Weitere Artikel der Ausgabe 9/2012

Supportive Care in Cancer 9/2012 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.